1Appelhoffl RJ, Tian Yamin, Raval RR, et al. Differential fnnction of the prolyl hydroxylases PHDI, PHD2, and PHD3 in the regulation of hypoxia-inducible factor [ J ]. Biol Chem, 2004,279 ( 37 ) : 38458-38465.
2Kato H, lnoue T, Asanoma Kazuo, et al. Induction of hu- man endometrial Cancer cell senescence through modula- tion of HIF-lalpha activity by EGLN1 [ J]. cancer,2006, 118(5) :1144-1153.
3Lee Kangae, Lynd JD, O'reilly S, et al. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential [ J ]. Mol Cancer Res, 2008,6 ( 5 ) : 829-842.
4Chan DA, Kawahara TA, Sutphin PD, et al. Tumor vaseula- ture is regulated by PHD2-Mediated angiogenesis and bone Marrow-Derived cell recruitment [J].Cancer Cell, 2009,15 (6) :527-538.
5Aprelikova O,Pandolfi S, Tackett S, et al. Melanoma anti- gen-11 inhibits the hypoxia-inducible factor prolyl hydrox- ylase 2 and activates hypoxic response [ J]. Cancer Res, 2009,69(2) :616-624.
6Xue Jing, Li Xuebing, Jiao Shi, et al. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity [ J ]. Gastroen- terology, 2010,138 ( 2 ) : 606 -615.
7Bordoli MR, Stiehl DP, Borsig L, et al. Prolyl-4-hydroxy- lase PHD2-and hypoxia-inducible factor 2-dependent reg- ulation of amphiregulin contributes to breast tumorigenesis [J]. Oncogene,2011,30(5) :548-560.
8Tan Ey, Yan M, Campo L, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy [ J ]. Br J Cancer,2009,100(2) :405-411.
9Couvelard A, Deschamps L, Rebours V, et al. Overexpres- sion of the Oxygen sensors PHD-1, PHD-2, PHD-3, and FIH is associated with tumor aggressiveness in pancreatic endocrine tumors [ J ]. Clin Cancer Res, 2008, 14 ( 20 ) : 6634-6639.
10Foca C, Rice GE, Quinn MA, et al. Identification and partial characterization of differentially expressed mR- NAs in normal human endometria and endometrial carci-nomas by differential display RT-PCR[ J]. Mol Hum Re- prod,2000,6 (8) :712-718.
7Li S,Yao D,Wang L,et al.Expression characteristicsof hypoxia-inducible factor-1 a and its clinical values indiagnosis and prognosis of hepatocellular carcinoma [J].Hepat Mon,2011,11(10):821-828.
8Tian YM,Mole DR,Ratcliffe PJ,et al.Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation[J].Biochem J,2006,397(1):179-186.
9Taylor MS.Characterization and comparative analysis ofthe EGLN gene family[J].Gene,2001,275(1):125-132.
10Oehme F,Ellinghaus P,Kolkhof P,et al.Overexpression of PH-4,a novel putative proline 4-hydroxylase,modulatesactivity of hypoxia-inducible transcription factors[J]. Biochem Biophys Res Commun,2002,296(2):343-349.
